House passes bill to reauthorize FDA user fee programs

Jun 09, 2022 - 02:53 PM
recissioin-legislation

The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding for the agency to review drugs, devices and biologics. Among other provisions, the bipartisan bill would include drugs on the FDA’s shortages list in a pilot program to designate advanced manufacturing technologies. The Senate Health, Education, Labor, and Pensions Committee will mark up their version of the bill Tuesday.

Related News Articles

Headline
FDA reports issues with certain reworked Philips ventilators
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…
Headline
FDA updates EUAs for COVID-19 antigen tests, alerts providers to device recall and shortage
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require…
Headline
FDA issues update on heart device recall
All hospitals may request a backup controller with modified software for the Heartware Ventricular Assist Device System to use in certain circumstances if the…
Headline
Exela sodium bicarbonate injection recalled due to potential for flying glass 
Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration…
Headline
FBI recommends action to protect vulnerable medical devices from cyberattacks
The FBI today released recommendations to help protect medical devices from cyberattacks that can threaten health care operations, patient safety, and…
Headline
FDA alerts providers to breathing device mask recall
Philips Respironics has recalled more than 17 million masks used with Bilevel Positive Airway Pressure and Continuous Positive Airway Pressure machines because…